ImmunityBio's total assets for Q3 2025 were $0.00, a decrease of -100.00% from the previous quarter. IBRX total liabilities were $569.82M for the fiscal quarter, a -41.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.